DK3973982T3 - Sammensætning til kontrolleret ovariestimulation - Google Patents

Sammensætning til kontrolleret ovariestimulation Download PDF

Info

Publication number
DK3973982T3
DK3973982T3 DK21196378.0T DK21196378T DK3973982T3 DK 3973982 T3 DK3973982 T3 DK 3973982T3 DK 21196378 T DK21196378 T DK 21196378T DK 3973982 T3 DK3973982 T3 DK 3973982T3
Authority
DK
Denmark
Prior art keywords
composition
ovarian stimulation
controlled ovarian
controlled
stimulation
Prior art date
Application number
DK21196378.0T
Other languages
English (en)
Inventor
Saez Joan-Carles Arce
Lisbeth Helmgaard
Bjarke Mirner Klein
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK3973982T3 publication Critical patent/DK3973982T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK21196378.0T 2017-09-01 2018-08-31 Sammensætning til kontrolleret ovariestimulation DK3973982T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17189119 2017-09-01
EP18768795.9A EP3675894B1 (en) 2017-09-01 2018-08-31 Composition for controlled ovarian stimulation

Publications (1)

Publication Number Publication Date
DK3973982T3 true DK3973982T3 (da) 2024-09-23

Family

ID=59772482

Family Applications (2)

Application Number Title Priority Date Filing Date
DK18768795.9T DK3675894T3 (da) 2017-09-01 2018-08-31 Sammensætning til kontrolleret ovariestimulation
DK21196378.0T DK3973982T3 (da) 2017-09-01 2018-08-31 Sammensætning til kontrolleret ovariestimulation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK18768795.9T DK3675894T3 (da) 2017-09-01 2018-08-31 Sammensætning til kontrolleret ovariestimulation

Country Status (32)

Country Link
US (2) US11744879B2 (da)
EP (3) EP3675894B1 (da)
JP (2) JP6856819B2 (da)
KR (2) KR20250078595A (da)
CN (2) CN111050787A (da)
AR (1) AR112541A1 (da)
AU (1) AU2018326556B2 (da)
BR (1) BR112020003379A2 (da)
CA (1) CA3073624A1 (da)
CL (1) CL2020000482A1 (da)
DK (2) DK3675894T3 (da)
EA (1) EA202090480A1 (da)
ES (2) ES2989511T3 (da)
FI (1) FI3973982T3 (da)
HR (2) HRP20241171T1 (da)
HU (2) HUE068024T2 (da)
IL (1) IL272763B2 (da)
JO (1) JOP20200034B1 (da)
LT (2) LT3675894T (da)
MA (2) MA56224B1 (da)
MD (2) MD3675894T2 (da)
MX (2) MX2020002235A (da)
MY (1) MY200791A (da)
PH (1) PH12020500404A1 (da)
PL (2) PL3675894T3 (da)
PT (2) PT3973982T (da)
RS (2) RS65945B1 (da)
SG (1) SG11202003840QA (da)
SI (2) SI3675894T1 (da)
TW (1) TWI749255B (da)
UA (1) UA126869C2 (da)
WO (1) WO2019043143A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
TW202237173A (zh) * 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2397680A1 (en) * 2000-01-27 2001-08-02 Applied Research Systems Ars Holding N.V. Use of fsh for treating infertility
US20040248784A1 (en) 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
ES2494928T3 (es) * 2007-09-21 2014-09-16 Pharmabrand S.A. Composición que comprende polisacáridos mucilaginosos derivados de Aloe barbadensis combinados con liposomas, procedimiento para la obtención de los mismos y su uso como protector solar, un agente antiacné, un regenerador epidérmico y un hidratante
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
WO2011089602A2 (en) * 2010-01-21 2011-07-28 Ramot At Tel-Aviv University Ltd. Aloe-emodin derivatives and use thereof for the treatment of cancer
PT2621517E (pt) 2010-09-29 2015-10-16 Ferring Bv Composição para uso no tratamento da infertilidade
EP2717904A1 (en) 2011-06-06 2014-04-16 Ferring BV Pharmaceutical preparation comprising recombinant fsh
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
MX2016013449A (es) * 2014-04-18 2017-05-04 Glycotope Gmbh Hiperestimulacion ovarica controlada con la hormona estimuladora folicular humana recombinante mejorada.
PL3261661T3 (pl) 2015-02-26 2024-03-25 Ferring B.V. Menotropina do leczenia niepłodności
EP3283097B1 (en) 2015-04-17 2020-02-12 Ferring B.V. Fsh for treatment of infertility
SI3286209T1 (sl) 2015-04-24 2021-01-29 Ferring Bv Postopek izdelave gonadotropina
MY179524A (en) 2015-06-26 2020-11-10 Ferring Bv Methods of purification and/or viral inactivation
HUE071268T2 (hu) 2018-04-30 2025-08-28 Ferring Bv Készítmény szabályozott petefészek-stimuláláshoz
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法

Also Published As

Publication number Publication date
MD3675894T2 (ro) 2022-03-31
RS65945B1 (sr) 2024-10-31
AR112541A1 (es) 2019-11-06
KR20200045543A (ko) 2020-05-04
CL2020000482A1 (es) 2020-06-26
HRP20241171T1 (hr) 2024-11-22
TW201919687A (zh) 2019-06-01
US11744879B2 (en) 2023-09-05
JOP20200034A1 (ar) 2020-02-13
SI3675894T1 (sl) 2022-01-31
EA202090480A1 (ru) 2020-07-20
IL272763B1 (en) 2023-10-01
MX2020002235A (es) 2020-07-20
PT3675894T (pt) 2022-01-25
TWI749255B (zh) 2021-12-11
FI3973982T3 (fi) 2024-09-23
US20200197493A1 (en) 2020-06-25
SI3973982T1 (sl) 2024-10-30
JP7373479B2 (ja) 2023-11-02
MA56224B1 (fr) 2024-09-30
US20240024424A1 (en) 2024-01-25
LT3675894T (lt) 2021-12-10
PL3675894T3 (pl) 2022-02-21
MD3973982T2 (ro) 2024-11-30
MA50034A (fr) 2021-05-12
EP3973982B1 (en) 2024-07-31
ES2904787T3 (es) 2022-04-06
DK3675894T3 (da) 2022-01-24
MA56224A (fr) 2022-04-20
MX2024009224A (es) 2024-08-06
JP2021046398A (ja) 2021-03-25
HUE056726T2 (hu) 2022-03-28
AU2018326556A1 (en) 2020-03-05
EP3973982A1 (en) 2022-03-30
RS62810B1 (sr) 2022-02-28
BR112020003379A2 (pt) 2020-08-25
CN120617484A (zh) 2025-09-12
IL272763B2 (en) 2024-02-01
PH12020500404A1 (en) 2021-03-01
MY200791A (en) 2024-01-16
EP4427806A3 (en) 2024-10-09
ES2989511T3 (es) 2024-11-26
JP6856819B2 (ja) 2021-04-14
CA3073624A1 (en) 2019-03-07
HRP20211802T1 (hr) 2022-03-04
UA126869C2 (uk) 2023-02-15
JOP20200034B1 (ar) 2024-04-18
EP3675894A1 (en) 2020-07-08
CN111050787A (zh) 2020-04-21
HUE068024T2 (hu) 2024-12-28
AU2018326556B2 (en) 2024-09-26
WO2019043143A1 (en) 2019-03-07
EP4427806A2 (en) 2024-09-11
KR20250078595A (ko) 2025-06-02
SG11202003840QA (en) 2020-05-28
PL3973982T3 (pl) 2024-11-04
MA50034B1 (fr) 2022-02-28
LT3973982T (lt) 2024-09-10
JP2020528071A (ja) 2020-09-17
EP3675894B1 (en) 2021-11-03
PT3973982T (pt) 2024-09-16
IL272763A (en) 2020-04-30

Similar Documents

Publication Publication Date Title
EP3722358A4 (en) COMPOSITION
DK3697376T3 (da) Sammensætning
DK3646326T3 (da) Fremgangsmåder til mikrobiomanalyse med høj opløsning
EP3493800A4 (en) CANNABIS
DK3787667T3 (da) Sammensætning til kontrolleret ovariestimulation
EP3663376A4 (en) WATER REPELLENT COMPOSITION
DK3528902T3 (da) Ringegelsammensætning
DK3277690T3 (da) Spirocykliske forbindelser
EP3480228A4 (en) COMPOSITION
DK3423533T3 (da) Sammensætning til multifunktionel gulvbehandling
EP3524627A4 (en) COMPOSITION
DK3416502T3 (da) Glykæmisk-reducerende sammensætning
EP3675653C0 (fr) Composition antimycotoxine
EP3612172C0 (en) ANTICANCER COMPOUNDS
DK3973982T3 (da) Sammensætning til kontrolleret ovariestimulation
EP3521505A4 (en) Composition
EP3458432C0 (en) FERTILIZER COMPOSITION
PL3481406T3 (pl) Kompozycja
DK3349752T3 (da) Aza-adamantan sammensætning til sårheling
ES1209313Y (es) Composicion liofilizada
DK3294682T3 (da) Sammensætning til overfladebehandling
EP3565570C0 (en) COMPOSITION
DK3410854T3 (da) Mikrobicid sammensætning
HK40021791A (en) Composition for controlled ovarian stimulation
IL266099A (en) Heterocyclic compound